U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07253363) titled 'Circulating Activin-A and FSTL3 in Precapillary Pulmonary Hypertension' on Nov. 19.
Brief Summary: The ACTIOBIO study aims to evaluate the prognostic value of Activin-A and FSTL3 in a large cohort of patients with precapillary pulmonary hypertension, including pulmonary arterial hypertension (Group 1), pulmonary hypertension associated with lung diseases (Group 3), and chronic thromboembolic pulmonary hypertension (Group 4).
Study Start Date: March 01, 2024
Study Type: INTERVENTIONAL
Condition:
Pulmonary Hypertension
Intervention:
OTHER: Biological collection
Serum, plasma, ADN
Recruitment Status: ACTIVE_NOT_RECRUITING
Spon...